Blood Clot Study for Newborns with Heart Disease

Extracellular Vesicle Micro RNA Profiling in Congenital Heart Disease: Fetal-Maternal Regulation in Neonatal Thrombosis

Recruiting Observational Study
Congenital Heart Disease Single-ventricle Thrombosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 7 Days
Sex
Any
Study type
Observational
Participants needed
10 (estimated)
Sponsor
Boston Children's Hospital · Other
Who this trial is looking for

This trial is looking for newborns diagnosed with severe congenital heart disease who will have surgery at Boston Children's Hospital during their first week of life. Participating involves giving a blood sample to help researchers understand why some babies have issues with blood clotting.

Are You a Good Fit for This Trial?

You may be able to join if

  • I have been diagnosed with severe congenital heart disease
  • I will have surgery at Boston Children's Hospital within the first week of life

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
Newborns with congenital heart disease (CHD) are at increased risk of developing postpartum and postoperative blood clots after cardiac surgery. The molecular mechanisms that are responsible for the clotting profile predisposing children to blood clots in the early stages of life are currently not well described. The goal of this proposal is to prospectively collect plasma samples from ten (10) n…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All neonates with a diagnosis of severe Congenital Heart Disease undergoing surgery at Boston Children's Hospital in the first week of life Exclusion Criteria: * None
Contacts

Rachel Bernier, MPH

857-218-5348

rachel.bernier@childrens.harvard.edu

CONTACT

Hanna Van Pelt, BS

hanna.vanpelt@childrens.harvard.edu

CONTACT